# Pawel Kalinski

Source: https://onco.cc/people/pawel-kalinski/  
OnCo record `pawel-kalinski` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Pawel Kalinski is an immunologist reprogramming tumour microenvironments so T cells can enter.

## Summary

Pawel Kalinski is Vice Chair for Translational Research in the Department of Medicine and Chief of Translational Immuno-Oncology at Roswell Park Comprehensive Cancer Center. He is an immunologist known for reprogramming tumour microenvironments so that T cells can enter, developing chemokine-modulating regimens that combine interferon, TLR3 agonists and COX-2 inhibition, alongside dendritic cell vaccines. His selected paper reviews chemokine modulation to enhance T cell infiltration of tumours. He continues to work on converting immune-excluded tumours to respond to checkpoint inhibitors.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Vice Chair for Translational Research, Department of Medicine; Chief, Translational Immuno-Oncology
- Specialisms: Dendritic cell vaccines; Chemokine modulation; Tumour microenvironment

## Sources

- Roswell Park profile: https://www.roswellpark.org/pawel-kalinski
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Kalinski%20P%5BAuthor%5D

## Connected records

- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- institutions: [Roswell Park Comprehensive Cancer Center](https://onco.cc/institutions/roswell-park/)
- terms: [Hot vs cold tumours](https://onco.cc/terms/cold-vs-hot/)
- journals: [Cancer Immunology Research](https://onco.cc/journals/cancer-immunology-research/)

---
JSON: https://onco.cc/api/v1/entities/pawel-kalinski.json